Royalty Payments. 3.1.1. In partial consideration for the rights and licenses granted pursuant to Section 2.1 (Grant of Rights), Licensee shall pay to Licensor royalties equal to five percent (5%) of the Net Sales of any Licensed Products in a Quarter.
Appears in 7 contracts
Samples: Agreement by And (Regen BioPharma Inc), Agreement by And (Regen BioPharma Inc), Agreement by And (Regen BioPharma Inc)
Royalty Payments. 3.1.13.3.1. In partial consideration for the rights and licenses granted pursuant to Section 2.1 (Grant of Rights), Licensee shall pay to Licensor royalties equal to five four percent (54%) of the Net Sales of any Licensed Products in a Quarter.
Appears in 4 contracts
Samples: Agreement by And (Regen BioPharma Inc), Agreement by And (Regen BioPharma Inc), Agreement by And (Zander Therapeutics, Inc)
